[
    [
        {
            "time": "2021-07-15",
            "original_text": "WHO says global COVID-19 cases nearly doubled in last two months, making vaccine drive more urgent than ever",
            "features": {
                "keywords": [
                    "global",
                    "COVID-19",
                    "cases",
                    "doubled",
                    "vaccine",
                    "urgent"
                ],
                "sentiment_score": -0.6,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "false",
                "ts_effect_direction": "none"
            },
            "scores": {
                "News_content": "WHO says global COVID-19 cases nearly doubled in last two months, making vaccine drive more urgent than ever",
                "Correlation": 6,
                "Sentiment": 4,
                "Importance": 8,
                "Impact": 5,
                "Duration": 7,
                "Entity_Density": 1,
                "Market_Scope": 9,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "2021-07-15",
            "original_text": "Glaxo (GSK)/ Vir Biotech COVID-19 Antibody Under Review in EU",
            "features": {
                "keywords": [
                    "Glaxo",
                    "Vir Biotech",
                    "COVID-19",
                    "Antibody",
                    "Review",
                    "EU"
                ],
                "sentiment_score": 0.4,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "none"
            },
            "scores": {
                "News_content": "Glaxo (GSK)/ Vir Biotech COVID-19 Antibody Under Review in EU",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 8
            }
        },
        {
            "time": "2021-07-15",
            "original_text": "UPDATE 2-Lilly asks FDA to not allow lone use of COVID-19 drug bamlanivimab",
            "features": {
                "keywords": [
                    "Lilly",
                    "FDA",
                    "COVID-19",
                    "drug",
                    "bamlanivimab"
                ],
                "sentiment_score": -0.3,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "false",
                "ts_effect_direction": "none"
            },
            "scores": {
                "News_content": "UPDATE 2-Lilly asks FDA to not allow lone use of COVID-19 drug bamlanivimab",
                "Correlation": 9,
                "Sentiment": 5,
                "Importance": 8,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "2021-07-15",
            "original_text": "Pharma Stock Roundup: JNJ's COVID-19 Vaccine Woes, MRK Ends COVID-19 Drug Development",
            "features": {
                "keywords": [
                    "Pharma",
                    "Stock",
                    "JNJ",
                    "Vaccine",
                    "Woes",
                    "MRK",
                    "Drug",
                    "Development"
                ],
                "sentiment_score": -0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "Pharma Stock Roundup: JNJ's COVID-19 Vaccine Woes, MRK Ends COVID-19 Drug Development",
                "Correlation": 8,
                "Sentiment": 3,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 7,
                "Market_Scope": 6,
                "Time_Proximity": 6,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        },
        {
            "time": "2021-07-15",
            "original_text": "Eli Lilly asks FDA to revoke EUA for COVID antibody treatment alone to speed transition to combination therapy",
            "features": {
                "keywords": [
                    "Eli Lilly",
                    "FDA",
                    "revoke",
                    "EUA",
                    "COVID",
                    "antibody",
                    "treatment",
                    "combination",
                    "therapy"
                ],
                "sentiment_score": -0.2,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "false",
                "ts_effect_direction": "none"
            },
            "scores": {
                "News_content": "Eli Lilly asks FDA to revoke EUA for COVID antibody treatment alone to speed transition to combination therapy",
                "Correlation": 10,
                "Sentiment": 6,
                "Importance": 9,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 10,
                "Market_Scope": 4,
                "Time_Proximity": 9,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "time": "2021-07-15",
            "original_text": "Lilly requests revocation of emergency use authorization for bamlanivimab alone to complete transition to bamlanivimab and etesevimab together for treatment of COVID-19 in the U.S.",
            "features": {
                "keywords": [
                    "Lilly",
                    "revocation",
                    "emergency",
                    "use",
                    "authorization",
                    "bamlanivimab",
                    "etesevimab",
                    "treatment",
                    "COVID-19",
                    "U.S."
                ],
                "sentiment_score": -0.3,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "false",
                "ts_effect_direction": "none"
            },
            "scores": {
                "News_content": "Lilly requests revocation of emergency use authorization for bamlanivimab alone to complete transition to bamlanivimab and etesevimab together for treatment of COVID-19 in the U.S.",
                "Correlation": 10,
                "Sentiment": 6,
                "Importance": 9,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 10,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 6,
                "Source_Recency": 8
            }
        },
        {
            "time": "2021-07-15",
            "original_text": "Premarket Movers Friday - DraftKings, Morgan Stanley, Splunk",
            "features": {
                "keywords": [
                    "Premarket",
                    "Movers",
                    "DraftKings",
                    "Morgan Stanley",
                    "Splunk"
                ],
                "sentiment_score": 0.2,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "technology",
                    "finance"
                ],
                "causal_factor": "false",
                "causal_impact": "none",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "Premarket Movers Friday - DraftKings, Morgan Stanley, Splunk",
                "Correlation": 3,
                "Sentiment": 5,
                "Importance": 4,
                "Impact": 4,
                "Duration": 3,
                "Entity_Density": 6,
                "Market_Scope": 7,
                "Time_Proximity": 9,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        }
    ]
]